Zenas BioPharma, Inc. Quarterly Liabilities, Current in USD from Q4 2023 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Zenas BioPharma, Inc. quarterly Liabilities, Current history and growth rate from Q4 2023 to Q2 2025.
Zenas BioPharma, Inc. Liabilities, Current for the quarter ending June 30, 2025 was $53.2M.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$53.2M			Jun 30, 2025	10-Q	2025-08-12
Q1 2025	$49.1M			Mar 31, 2025	10-Q	2025-05-15
Q4 2024	$57.3M	+$34M	+146%	Dec 31, 2024	10-Q	2025-08-12
Q3 2024	$44M			Sep 30, 2024	10-Q	2024-11-12
Q4 2023	$23.3M			Dec 31, 2023	10-K	2025-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.